2026-01-13 - Analysis Report
**English Report**

### 1. Company Overview
Equinix Inc is a technology company providing data center and colocation services.

### 2. Return Rate Comparison
- The cumulative return of EQIX is 29.91%
- The cumulative return of VOO (S&P 500) is 94.34%
- Degree of divergence: -64.43%

### Simple Analysis
The return rate of EQIX is significantly lower than that of VOO, indicating a high degree of risk and potential underperformance over the long term.

### 3. Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta       |
|------------|------|------|-------|------------|
| 2016-2018  | -11.0% | 20.2% | -15.0% | 34.6B      |
| 2017-2019  | 15.0% | 20.2% | -2.0%  | 57.3B      |
| 2018-2020  | 23.0% | 20.2% | 3.0%   | 70.1B      |
| 2019-2021  | 68.0% | 14.2% | 25.0%  | 83.0B      |
| 2020-2022  | -4.0% | 37.2% | -3.0%  | 64.3B      |
| 2021-2023  | -20.0% | 37.2% | -21.0% | 79.1B      |
| 2022-2024  | -5.0% | 33.4% | -24.0% | 92.6B      |
| 2023-2025  | -3.0% | 22.4% | -66.0% | 75.2B      |

### Simple Analysis
The performance of EQIX has been volatile over the years, with both positive and negative returns. Beta values indicate a high level of volatility compared to other stocks.

### 4. Stock Price Fluctuations
| Metric     | Figur    |
|------------|----------|
| Close      | $783.86  |
| Last-market | {'price': 783.86, 'previousClose': 800.35, 'change': -2.06} |
| 5-day SMA  | $786.14  |
| 20-day SMA | $766.40  |
| 60-day SMA | $781.22  |

### Simple Analysis
The stock price of EQIX has shown a moderate decline over the past 5 days, but remains above the 20-day SMA.

### 5. RSI, PPO Index Indicators
- Market Risk Indicator (MRI): 0.80
- RSI: 63.13
- PPO: 0.54
- Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.80)
- Recent (20 days) relative divergence change: 3.20 (+): improving
- 7-day Rank change: 1 (+): rank up
- 7-day Dynamic Expected Return change: 90.40 (+): improving
- Expected Return (%): -177.60%

### Simple Analysis
The stock is at a higher risk level due to the MRI of 0.80, but recent indicators suggest an improving trend.

### 6. Recent News & Significant Events
* [2026-01-12] BofA Securities reiterates Buy rating on Equinix stock with $950 price target - Investing.com
* [2026-01-12] YieldBoost EQIX To 7.8% Using Options - Nasdaq
* [2026-01-10] Is Wall Street Bullish or Bearish on Equinix Stock? - MSN
* [2026-01-08] Should You Hold Equinix (EQIX)? - Yahoo Finance
* [2026-01-12] Assessing Equinix (EQIX) Valuation As Analyst Optimism Meets AI Infrastructure Expectations - simplywall.st

### Simple Analysis
Analysts are bullish on the stock with a majority rating of "Buy" and a high target price of $950.

### 7. Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.63 (~Buy)
- Opinions: 26
- Target Price (avg/high/low): 955.65 / 1200.00 / 785.00
```

### Simple Analysis
Analysts have a consensus of "Buy" with a mean rating of 1.63, indicating a high level of confidence in the stock.

### 8. Recent Earnings Analysis
| Date | EPS | Revenue |
|-----|----|---------|
| 2025-10-29 | 3.82 | 2.32 B$ |
| 2025-07-30 | 3.76 | 2.26 B$ |
| 2025-04-30 | 3.52 | 2.23 B$ |
| 2024-10-30 | 3.11 | 2.20 B$ |
| 2025-10-29 | 3.11 | 2.20 B$ |

### Simple Analysis
EPS has been consistent over the past few quarters, with a decline in revenue.

### 9. Financial Information
#### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $2.32B | 50.69% |
| 2025-06-30 | $2.26B | 51.95% |
| 2025-03-31 | $2.23B | 51.28% |
| 2024-12-31 | $2.26B | 47.10% |
| 2024-09-30 | $2.20B | 50.11% |

#### Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $14.16B | 2.64% |
| 2025-06-30 | $14.08B | 2.61% |
| 2025-03-31 | $13.89B | 2.47% |
| 2024-12-31 | $13.53B | -0.10% |
| 2024-09-30 | $13.59B | 2.19% |

### Simple Analysis
The company has shown a stable revenue with a consistent profit margin over the past few quarters.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.